Chondrocalcinosis as a cause of mulitarticular destructive arthropathy;Destruierende multilokuläre Arthropathie bei Chondrokalzinose Kasuistik und Literaturübersicht

Aktuelle Rheumatologie

Volumn 27, Issue 1, 2002, Pages 33-37

  Carl, Hans Dieter ^a   Swoboda, B ^a   Schmidt, R ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; CALCIUM PYROPHOSPHATE; URATE;

ADULT; ARTHROPATHY; ARTICLE; CASE REPORT; CHONDROCALCINOSIS; CLINICAL EXAMINATION; DISEASE ASSOCIATION; HUMAN; MALE; PATHOGENESIS;

EID: 0036175109     PISSN: 0341051X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-20142     Document Type: Article

References (26)

1. Fever of unknown origin as a sign of calcium pyrophosphate deposition disease
2. Calcium crystal effects on the cell of the joint: Implications for pathogenesis of disease
3. Chronic tophaceous gout with severely deforming arthritis: A case report with emphasis on histopathologic considerations
4. What is the relation between crystals and osteoarthritis?
5. Pyrophosphate arthropathy: A clinical and radiological study of 105 cases
6. Tophaceous gout mimicking tumoral growth
7. Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition disease in the knee
8. Role of the mouse ank gene in control of tissue calcification and arthritis
9. Crystal deposition disease. Diagnosis by electron microscopy
10. Mixed monosodium urate and calcium pyrophosphate crystal-induced arthropathy. A review of seventeen cases
11. An unusual systemic presentation of gout
12. The mitogenic response to stimulation with basic calcium phosphate crystals is accompanied by induction and secretion of collagenase in human fibroblasts
13. Molecular mechanism of basic calcium phosphate crystal-induced activation of human fibroblasts. Role of nuclear factor Kappa b, activator protein 1, and protein kinase C
14. Management of crystal arthritis
15. Alizarin red staining as a screening test to detect calcium compounds in synovial fluid
16. Do we really need to pay attention to the less common crystals?
17. Clinical, radiographic and pathologic abnormalities in calcium pyrophosphate dihydrate deposition disease (CPPD)
18. Treatment of refractory crystal-associated arthritis
19. Prospective 6-month double-blind trial of hydroxychloroquine treatment of CPDD
20. Tumoral calcium pyrophosphate deposition disease
21. Submicroscopic crystals in osteoarthritic synovial fluids
22. Corticoid therapy for the treatment of acute attacks of crystal-induced arthritis: An effective alternative to nonsteroidal antiinflammatory drugs